Skip to main content
. 2017 Aug 4;8(35):59048–59057. doi: 10.18632/oncotarget.19937

Table 2. Univariate and multivariate cox regression analyses for overall survival in patients with ESCC in primary cohort.

Variables Univariate analysis Multivariate analysis
HR (95%CI) P value HR (95%CI) P value
Sex
 Male vs. Female 0.69 (0.43–1.13) 0.141
Age
 ≥ 60 years vs. < 60 years 0.94 (0.64–1.37) 0.737
Histological grade 0.002* 0.011*
 Well differentiated Ref. Ref.
 Moderately differentiated 2.90 (0.90–9.31) 0.074 1.77 (0.54–5.78) 0.346
 Poorly or not differentiated 4.87 (1.52–15.59) 0.008* 2.99 (0.92–9.75) 0.069
Tumor location 0.900
 Upper Ref.
 Middle 0.89 (0.41–1.96) 0.778
 Lower 0.84 (0.38–1.88) 0.672
Examined lymph nodes
 ≥ 15 vs. < 15 0.81 (0.55–1.19) 0.285
T stage < 0.001* < 0.001*
 T1 Ref. Ref.
 T2 2.12 (1.17–3.85) 0.013* 2.01 (1.10–3.68) 0.023*
 T3 3.77 (2.20–6.47) < 0.001* 3.46 (2.00–5.98) < 0.001*
ZFAS1
 Low vs. High 1.89 (1.28–2.79) 0.002* 1.59 (1.07–2.36) 0.022*